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Abstract: We investigated the healing process on excisional wounds infected with 
Staphylococcus aureus in rats, treated with 50 μL of ethyl acetate III from Vernonia 
scorpioides (Lam.) Pers., Asteraceae, rifamycin diethylamide B 25 mg, or saline. 
The lesions were measured daily and after seven days were surgically removed 
and histologically processed. The results indicate a favorable action of the EAIII, 
demonstrated by the increased wound contraction, smaller area of necrotic tissue, 
good development of granulation tissue, extensive extracellular matrix deposition 
and epithelial regeneration. This sub-fraction was phytochemically investigated 
in parallel studies, revealing the presence of sesquiterpene lactones (glaucolides 
and hirsutinolides) such as diacethylpiptocarphol and related hirsutinolides, 
flavonoids and cinnamic acid derivatives and also a new polyacetylene, which 
have been previously published. Results support the effectiveness of V. scorpioides 







 The tribe Vernonieae belongs to the family 
Asteraceae, and includes sesquiterpene lactones. 
There are about 200 species of Vernonia in Brazil, 
some of which are traditionally used in folk medicine 
(Lopes, 1991). Different biological effects of the 
sesquiterpene lactones species from Vernonia are 
described. The decoction of V. amygdalina showed to 
be a safe and moderately clinically effective treatment 
for malaria in adult semi-immune patients with no 
severe adverse events (Challand & Willcox, 2009); the 
seeds from V. anthelmintica possess antidiabetic and 
antihyperlipidemic properties without evident toxic 
effects (Fatima et al., 2010); V. amygdalina extracts 
exhibit anti tumor activity (Oyugi et al., 2009); methanol 
extract from V. cinerea demonstrates anti-inflammatory 
properties (Pratheeshkumar & Kuttan, 2009); and V. 
amygdalina ethanol and aqueous extracts inhibited the 
growth of Staphylococcus aureus (Gram-positive) and 
Escheriachia coli (Gram-negative) and showed activity 
against Candida albicans (Okigbo & Mmeka, 2008).
 Vernonia scorpioides (Lam.) Pers., Asteraceae, 
is very common in Brazil and usually grows in poor, 
deforested soils (Cabrera & Klein, 1980). Previous 
studies of V. scorpioides crude extract and its 
derived chloroform and hexane fractions have shown 
fungicide and moderate bactericide activity (Freire 
et al., 1996), and its use as a treatment for mange 
(scabies) has been recorded (Lans et al., 2001). In 
mice, the dichloromethane fraction (5 mg/kg) from 
the crude extract totally inhibited tumor development 
(Pagno et al., 2006), while subfraction 2125 from the 
crude extract (5mg/kg) inhibited tumor growth in the 
Sarcoma 180 ascitic tumor model in mice (Kreuger et 
al., 2009). The topical use of its alcoholic extract (200 
mg of the V. scorpioides hydrogel) showed mild wound 
healing effects in rats when the wounds were treated 
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topically for 30 days (Leite et al., 2002), although non-
infected skin ulcers treated with an ointment 20% of the 
crude concentrated extract from V. scorpioides with solid 
Vaseline and lanoline (1:2) showed toxicity for the tissues 
when applied immediately after the incision in mice. The 
daily treatment presented enlarged damaged areas in the 
skin wounds after seven days, when compared with the 
control. However, this concentration did not inhibit the 
influx of mononuclear leukocytes, the proliferation of 
fibroblasts, or the formation of blood vessels observed 
after fourteen days (Dalazen et al., 2005). 
 Foot complications are common in diabetic 
patients; foot ulcers are among the more serious 
consequences. These ulcers frequently become 
infected, and if not treated promptly and appropriately, 
diabetic foot infections can lead to septic gangrene and 
amputation. Staphylococcus aureus is the most common 
pathogen in these infections, and the increasing incidence 
of methicillin-resistant S. aureus (MRSA) over the past 
two decades has further complicated antibiotic treatment 
(Nicolau & Stein, 2010). Treatment of MRSA can include 
use of antibiotics; topical therapies such as honey, 
topical silver, and gentian violet; and bacteriophages 
(Durai et al., 2010). In human skin ulcer, a significant 
increase in MRSA was detected, where S. aureus was the 
predominant organism (Harrington et al., 2010). There 
is an urgent need to find new drugs that will be effective 
against bacteria that are resistant to the currently available 
antibiotic therapy.
 Infection is a well-recognized barrier to healing, 
and multiple variables contribute to its development 
(Bowling et al., 2009). Inflammation and healing are 
processes that are extremely complex and intricate, and 
is disorganized in chronic non-healing ulcers on the legs. 
The healing process involves the interaction of multiple 
groups of cells, extracellular matrix molecules and 
growth factors, and is affected by vascular insufficiency, 
the severity of the injury, and the presence of infection. 
The antimicrobial treatment of tissues after injury is 
determined by the mechanism of injury, time from injury 
to treatment, wound contamination, pathogenicity of 
colonizing bacteria in the lesion, and factors relating 
to the patients themselves (Lipsky et al., 2006). The 
ideal therapy for skin ulcers would suppress excessive 
inflammation and increase the power of healing (Daróczy, 
2006).
 We studied the development of the wound 
healing in an established cutaneous wound healing 
model infected with S. aureus and treated with ethyl 
acetate III (EAIII) obtained from V. scorpioides. We 
then evaluated their effects on the parameters of healing 
in rats, quantifying the extent of wound contraction, 
damaged tissue, granulation tissue, and re-epithelization 
in a quantifiable fashion.
 
Materials and Methods 
Plant material
 Flowers and leaves of Vernonia scorpioides 
(Lam.) Pers., Asteraceae, were collected from wild 
specimens of “restinga” forest (a type of coastal tropical 
and subtropical moist broadleaf forest) in Navegantes-
SC, Brazil), in September 2006, and identified by Dr. Ana 
Claudia Araújo of the Universidade do Vale do Itajaí.  A 
voucher specimen (M. Biavatti 11) was deposited at the 
Barbosa Rodrigues Herbarium, Itajaí, Santa Catarina, 
Brazil.
Extract, fractions and sample preparation
 Flowers and fresh leaves of V. scorpioides (5 kg) 
were extracted with ethanol (18 L) at room temperature, 
in the absence of light, for thirty days. The ethanol was 
then removed using a rotary evaporator. 1/3 of water (2 L) 
was added to the crude extract obtained, and the extract 
was submitted to liquid-liquid fractioning using solvents 
with increasing polarities. The respective fractions 
obtained were denominated: n-hexane I (HEX I, 16.16 g), 
dichloromethane I (DCM I, 136 g), ethyl acetate I (EA I, 
560 mg), and water. The dichloromethane I fraction was 
initially subjected to silica gel column chromatography 
(CC) (60-230 mesh) eluted with n-hexane, followed by 
dichloromethane, ethyl acetate and methanol, yielding 
subfractions for each of the four solvents: n-hexane (HEX 
II, 320 mg), dichloromethane (DCM II, 84 g), ethyl acetate 
(EA II, 560 mg). The dichloromethane II subfraction was 
subjected to silica gel CC (230-400 mesh) and eluted 
again with n-hexane, followed by dichloromethane, ethyl 
acetate and methanol, yielding new subfractions of each 
of the four solvents (III series). 
Microorganism, media and inocula
 For the antimicrobial evaluation, S.aureus ATCC 
6538P was used, a strain from the American Type Culture 
Collection (ATCC), Rockville, MD, USA. The bacteria 
were cultivated on Mueller-Hinton agar (MHA-Difco) 
at 35 oC for 24 h. Cell suspension in saline (0.86%) was 
adjusted to give a final concentration of 1.5x108 cell/mL, 
standardized with 0.5 on the McFarland scale (λ=530 nm) 
(NCCLS, 2006).
Quantitative antimicrobial evaluation in vitro
 The minimum inhibitory concentration (MIC) 
was determined by the agar dilution method, according 
to reported procedures (Campos et al., 2007), which was 
carried out on slants (1 mL). Stock solutions of ethyl 
acetate III (EAIII) in dimethylsulfoxide (DMSO) was 
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diluted to give serial two-fold dilutions, which were added 
to medium (MHA), resulting in concentrations ranging 
from 0.010 to 10 mg/mL. Afterwards, a volume of 1 µL 
of inoculum suspension, prepared previously, was added 
to each slant, with the exception of the sterile control, 
and incubated at 35 oC for 24 h. The fi nal concentration 
of DMSO in the assay did not exceed 2%. A drug-free 
solution was used as blank control. Each assay was 
repeated three times. The MIC was defi ned as the lowest 
concentration of compound at which the microorganism 
tested did not demonstrate visible growth. The minimum 
bactericidal concentration (MBC) was defi ned as the 
lowest concentration yielding negative subcultures.
Animals
 Eighteen Wistar rats (250-300 g) obtained from 
the Central Animal Facility of Univali, were used (six 
animals per group). They were kept in individual cages 
in standard environmental conditions, with free access 
to water and standard pellet food. The animals were 
used after an acclimatization period of seven days and 
the experiments were conducted in accordance with the 
Univali Ethics Committee. All procedures involving 
animals were approved by the institutional committee on 
the care and use of animals at our institution (protocol 
number 172/08, CEP-UNIVALI).
Excision wound model and histopathological analysis
 The animals were anesthetized with Ketamine 
2% (König Laboratories-Brazil) and Xilazine 6% (Calier 
Laboratories-Brazil). The back of each rat was shaved 
and the skin excised using a round biopsy incisor (Stiefel 
Laboratories-USA), to obtain a wound area of 5 mm. 
Each lesion received a suspension containing 50 µL of 
inoculum of S. aureus. 24 h after infection, the animals 
were divided into three groups, according to the treatment, 
Group I (n=5), topical application with 50 µL of EAIII (5 
mg/kg), Group II (n=5), topical application with 50 µL of 
rifamycin diethylamide B (Rifocin M®) 25 mg, group III 
(n=5) topical application with 50 µL of saline solution, for 
seven days. The animals were then sacrifi ced, after being 
anesthetised and infused through the left ventricle with 
0.9% saline solution and subsequently, with 10% formalin 
solution. The lesions were surgically removed and the 
skin specimens were fi xed in 10% buffered formaldehyde 
and embedded in paraffi n wax. After routine pathological 
procedures, sections of 5 μm in thickness were mounted 
on slides and stained with hematoxylin and eosin (HE). 
The slides were examined under light microscopy by a 
specialized pathologist. A single blind evaluation of two 
sets of serial sections from each lesion was carried out. A 
reticule eyepiece with 100 squares was used to measure 
the percentage of the damaged area, granulation tissue 
and epithelium regeneration, at a magnifi cation of 10x 
using an optical microscope. The averages of three sets 
were determined. The ulcer size and histopathological 
grading scores were also recorded.
Analysis of ulcer contraction
 The wounds on the backs of the rats were treated 
daily and measured at the end of each treatment. The two 
largest dimensions of each lesion were measured using 
a digital caliper and the area was calculated in mm2. 
The fi nal measure was subtracted from the initial value 
(5 mm) and the result was considered the value of the 
contraction. 
Figure 1. HPLC chromatogram of the ethyl acetate (EAIII) fraction of Vernonia scorpioides (260 nm). The peak at 23.51 min is the 
sesquiterpene lactone diacethylpiptocarphol. 
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Statistical analysis
 Significant differences were compared using 
analysis of variance (ANOVA) and Tukey’s test. The 
level of significance was determined at p<0.05.
HPLC analysis of EAIII
 The fraction and the reference compound 
(diacethylpiptocarphol) (100 µg/mL) were analysed 
on a Synergi Fusion-RP (250×4.6 mm, 5 μm) column 
(Phenomenex). The solvent system was composed of A 
(acetonitrile) and B (water with 0.5% acetic acid), with 
an elution program performed as follows: 0-5 min 20% of 
A, 6-35 min 20% to 80% of A; 3540 min, 20% of A; kept 
for 10 min. The total analysis time was 50 min and the 
flow rate was of 0.8 mL/min. The injection volume was 
20 μL, with detection at 260 nm. The HPLC instrument 
was a Perkin Elmer (200 series) equipped with an UV-
Vis detector. Data analyses were carried out using the 
TotalChrom software (Perkin Elmer).
Results
 The effects of V. scorpioides infected skin 
ulcers were determined by observing the development 
of the lesions after seven days of treatment with ethyl 
acetate III. The contraction of the wound healing and the 
histological evaluation showed that animals treated with 
EAIII obtained from V. scorpioides extract (Group I) 
presented faster wound healing, compared with animals 
treated with rifamycin (Group II) and saline solution 0.9% 
(Group III). After seven days, group I showed higher 
wound contraction and better histological findings than 
the other groups, such as absence of necrotic area and 
abscess, presence of granulation tissue, formation of new 
extracellular matrix, and epithelium repair. According to 
the HPLC conditions mentioned earlier, a chromatogram 
of the ethyl acetate III fraction was obtained (Figure 1). 
The previously isolated sesquiterpene lactone was not 
the major compound shown at this wavelength. The main 
compounds isolated from EAIII are diacethylpiptocarphol 
(1), ethyl caffeate (2), apigenin (3), luteolin (4) and the 
polyacetylene 5-(octa-2,4,6-triynyl)furan-2(5H)-one (5) 
(Buskuhl et al., 2009; 2010).
In vitro assay
 Antibacterial activity of the EAIII was 
determined by the dilution agar assay, as this method is 
especially good for determining the relative potency of 
polar and non-polar substances, as well as all types of 
complex extracts. The results of minimal inhibitory and 
bactericidal concentrations (MIC and MBC) displayed 
values of 1.25 and 2.5 mg/mL, respectively.
 Analysis of wound contraction
 After seven days, lesions treated with the 
EAIII presented greater wound contraction (3.01 mm), 
compared with the treatment with rifamycin (1.96 mm) 
and saline solution (1.6 mm). The value was considered 
statistically significant (p<0.005) when comparing the 
group treated with the studied fraction with the group 
treated with rifamycin and saline solution (Figure 2).
Histological analysis of necrotic tissue, clotting and 
crust
 Ulcers treated with EAIII (Group I) presented 
less damaged area, verified by the presence of necrotic 
tissue, clotting and crust, compared with the treatment 
of the other two groups. All the lesions from groups II 
and III presented necrotic tissue, and in group I, only one 
ulcer still showed damaged area (Figure 3). The value was 
considered statistically significant (p<0.05) in relation to 
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Total epithelium repair was observed in the treatment 
with EAIII, except in one ulcer. Treatment with rifamycin 
showed similar results, but with the presence of some 
ulcers with two-thirds of its width covered by epithelium 
(n=2) and in the group treated with saline solution 0.9%, 
most of the ulcers presented repair of less than one 
third of the epithelium width (n=4), (Figure 3). These 
microscopic findings were confirmed by histological 
assessment of wound re-epithelialization (Figure 4A, 4B 
and 4C).
Figure 2. Effect of the application of EAIII, rifamycin and 
saline solution on cutaneous wound closure rate. The data for 
wound closure are expressed in millimeters (mm). All data are 
mean SD p<0.005 different from Vernonia scorpioides-treated 
wounds in control animals. 
treatment daily, observed in the wound sections stained 
with HE. (Figures 4A, 4B and 4C)
Histological analysis of granulation tissue and new 
extracellular matrix formation 
 The treatment with EAIII from V. scorpioides 
and the treatment with rifamycin presented similar 
formation of granulation tissue after seven days, the 
proportions of tissue formation being lower compared 
with the treatment with saline solution, due of the larger 
area of contraction, particularly in the group treated with 
EAIII (Figure 2), and also because the treated lesions 
showed a higher percentage of new extracellular matrix 
and connective tissue with fibrosis compared with the 
other groups (Figure 3). However the values were not 
considered statistically significant. Granulation tissue 
and new extracellular matrix formation can be verified 
by the wound sections stained with HE, in which the 
connective tissue showed mild fibrosis and a higher 
amount of inflammatory cells in the lesions that received 
saline solution, compared with the other treatments. 
(Figures 4A, 4B and 4C).  
Histological analysis of wound re-epithelialization
 For the epithelial tissue analysis, the width of the 
wound covered by epithelial cells was taken into account. 
Figure 3. Percentage of necrotic tissue (A), granulation tissue (B), new extracellular matrix formation (C) and re-epithelialization 
(D). The ulcers were treated with EAIII, rifamycin and saline solution examined seven days after induction. The value for necrotic 
tissue was considered statistically significant (p<0.05) in relation to the treated group and control (rifamycin) compared with 
the group treated with saline solution. The data corresponds to the mean of the three areas examined, at a magnification of 10x 
(n=5). 
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Discussion
 Wound healing is characterized by re-
epithelialization, granulation tissue growth and 
remodeling of extracellular matrix. Although the wound 
healing process occurs by itself, spontaneously, and does 
not require much help, there are various risk factors such 
as infection, supply of blood, nutritional status and other 
factors that influence the resolution of this process (Lipsky 
et al., 2006). It is well known that attack by microbes, 
which invade the skin barrier, delays the natural wound-
healing process (Pattanayak & Sunita, 2008). MRSA is 
increasing in infections and is a serious threat to patients 
in health care facilities and the community. Resistance 
to common antibiotics makes treating MRSA costly and 
difficult. The main end point observed in this study - 
wound contraction and collagen synthesis were clearly 
accelerated by treating the wounds with EAIII, although 
all the parameters observed (presence of necrotic tissue, 
clotting and crust, re-epithelialization and granulation 
tissue growth) were affected, suggesting a pro-healing 
activity of this studied fraction. Topical application of V. 
scorpioides EAIII at the wound site produced significant 
wound healing activity, indicating that plant compounds 
can have an antibacterial effect, based on the fact that the 
formation of abscesses on the ulcer surface in vivo was not 
observed. The studied fraction also promoted antibacterial 
activity in vitro, but there is little information available 
on the antimicrobial property of V. scorpioides. Bardón 
et al. (2007) tested antimicrobial activity of several 
plants by the diffusion method, and showed that extracts 
of this plant presented activity against S. aureus. These 
results were corroborated in our findings. In Brazilian 
folk medicine, topical application of the ethanol extract 
of fresh leaves of V. scorpioides is used to treat various 
skin disorders, including chronic wounds and ulcers. 
Ulcers of the lower limb and foot frequently become 
infected with S. aureus, which is the most common 
pathogen in these infections (Nicolau & Stein, 2010) 
and if it is not treated promptly and appropriately, the 
treatment becomes more difficult, because the infection 
presents a barrier to healing (Bowling et al., 2009). It 
was demonstrated that non-infected skin ulcers treated 
with crude extract of V. scorpioides showed toxicity to 
the tissues when applied immediately after non-infected 
incision in mice (Dalazen et al., 2005). The crude extract 
can be dangerous in the initial wound healing stage in 
non-infected lesions, but our results showed that in 
infected ulcers this is not the case, indicating a possible 
antibacterial activity of V. scorpioides compounds. In 
the tribe Vernonieae (family: Asteraceae) sesquiterpene 
lactones (Lopes, 1991) are found, for which the different 
Figure 4. Wound healing seven days after experimental skin excision under different treatment conditions: (A) At both sides, 
the rim of the wound can be seen (lines) in the lesion treated with EAIII of Vernonia scorpioides, indicating greater wound 
contraction compared with the rifamycin treatment (B) and the saline solution treatment (C). In B and C, more necrosis and 
interrupted epithelium (arrow) can be seen, as well as more extensive formation of granulation tissue in C. (HE- 4x).
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biological effects are described. The data suggest that 
these compounds have anti-inflammatory and anti-ulcer 
(Feltenstein et al., 2004), anti-malarial (Chung & Moon, 
2009), and antibacterial (Ntutelaa et al., 2009, Saroglou 
et al., 2010) properties. These results could be related to 
the α,β-unsaturated carbonyl groups in these compounds, 
which seems to be important for their cytotoxicity (Lee 
et al., 1971). The EAIII evaluated in this work was 
phytochemically investigated in parallel, revealing the 
presence of sesquiterpene lactones (glaucolides and 
hirsutinolides) such as diacethylpiptocarphol and related 
hirsutinolides, flavonoids and cinnamic acid derivatives 
(Buskuhl et al., 2010), and also a polyacetylene (Buskuhl 
et al., 2009) (Figure 1). 
 In conclusion, in our study, besides the 
antibacterial activity observed in vitro, the in vivo 
evaluations showed faster resolution of scars in ulcers 
infected with S. aureus and treated with V. scorpioides 
ethyl acetate III. These results support the effectiveness 
of V. scorpioides in infected wound healing in rats.
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